224 related articles for article (PubMed ID: 25199777)
1. In vitro potential of Lycosin-I as an alternative antimicrobial drug for treatment of multidrug-resistant Acinetobacter baumannii infections.
Wang L; Wang YJ; Liu YY; Li H; Guo LX; Liu ZH; Shi XL; Hu M
Antimicrob Agents Chemother; 2014 Nov; 58(11):6999-7002. PubMed ID: 25199777
[TBL] [Abstract][Full Text] [Related]
2. Confronting multidrug-resistant Acinetobacter baumannii: a review.
Neonakis IK; Spandidos DA; Petinaki E
Int J Antimicrob Agents; 2011 Feb; 37(2):102-9. PubMed ID: 21130607
[TBL] [Abstract][Full Text] [Related]
3. Infection Control Programs and Antibiotic Control Programs to Limit Transmission of Multi-Drug Resistant Acinetobacter baumannii Infections: Evolution of Old Problems and New Challenges for Institutes.
Chen CH; Lin LC; Chang YJ; Chen YM; Chang CY; Huang CC
Int J Environ Res Public Health; 2015 Jul; 12(8):8871-82. PubMed ID: 26264006
[TBL] [Abstract][Full Text] [Related]
4. The Spider Venom Peptide Lycosin-II Has Potent Antimicrobial Activity against Clinically Isolated Bacteria.
Wang Y; Wang L; Yang H; Xiao H; Farooq A; Liu Z; Hu M; Shi X
Toxins (Basel); 2016 Apr; 8(5):. PubMed ID: 27128941
[TBL] [Abstract][Full Text] [Related]
5. [Antibiotic resistance of Acinetobacter baumannii strains isolated from clinical specimens in the "Marius Nasta" Pneumology Institute, Bucharest].
Moisoiu A; Ionită M; Sârbu L; Stoica C; Grigoriu L
Pneumologia; 2014; 63(2):109-11. PubMed ID: 25241558
[TBL] [Abstract][Full Text] [Related]
6. In vitro activity of tigecycline in combination with cefoperazone-sulbactam against multidrug-resistant Acinetobacter baumannii.
Liu B; Bai Y; Liu Y; Di X; Zhang X; Wang R; Wang J
J Chemother; 2015 Oct; 27(5):271-6. PubMed ID: 25068186
[TBL] [Abstract][Full Text] [Related]
7. Identification and characterization of novel isothiazolones with potent bactericidal activity against multi-drug resistant Acinetobacter baumannii clinical isolates.
Luna BL; Garcia JA; Huang M; Ewing PJ; Valentine SC; Chu YM; Ye QZ; Xu HH
Int J Antimicrob Agents; 2019 Apr; 53(4):474-482. PubMed ID: 30593847
[TBL] [Abstract][Full Text] [Related]
8. Cationic amphiphilic alpha-helical peptides for the treatment of carbapenem-resistant Acinetobacter baumannii infection.
Huang Y; Wiradharma N; Xu K; Ji Z; Bi S; Li L; Yang YY; Fan W
Biomaterials; 2012 Dec; 33(34):8841-7. PubMed ID: 22925814
[TBL] [Abstract][Full Text] [Related]
9. In vitro activity of several antimicrobial peptides against colistin-susceptible and colistin-resistant Acinetobacter baumannii.
Vila-Farres X; Garcia de la Maria C; López-Rojas R; Pachón J; Giralt E; Vila J
Clin Microbiol Infect; 2012 Apr; 18(4):383-7. PubMed ID: 21672084
[TBL] [Abstract][Full Text] [Related]
10. Synergy of imipenem/colistin methanesulfonate combinations against imipenem-nonsusceptible multidrug-resistant Acinetobacter baumannii.
Leu HS; Ye JJ; Lee MH; Su LH; Huang PY; Wu TL; Huang CT
J Microbiol Immunol Infect; 2014 Oct; 47(5):406-11. PubMed ID: 23834782
[TBL] [Abstract][Full Text] [Related]
11. Susceptibility patterns and molecular epidemiology of multidrug-resistant Acinetobacter baumannii strains from three military hospitals in China.
Yan ZQ; Shen DX; Cao JR; Chen R; Wei X; Liu LP; Xu XL
Int J Antimicrob Agents; 2010 Mar; 35(3):269-73. PubMed ID: 20036519
[TBL] [Abstract][Full Text] [Related]
12. Multidrug resistant and extensively drug resistant Acinetobacter baumannii hospital infection associated with high mortality: a retrospective study in the pediatric intensive care unit.
Shi J; Sun T; Cui Y; Wang C; Wang F; Zhou Y; Miao H; Shan Y; Zhang Y
BMC Infect Dis; 2020 Aug; 20(1):597. PubMed ID: 32787942
[TBL] [Abstract][Full Text] [Related]
13. Antimicrobial and Anti-Biofilm Peptide Octominin for Controlling Multidrug-Resistant
Jayathilaka EHTT; Rajapaksha DC; Nikapitiya C; De Zoysa M; Whang I
Int J Mol Sci; 2021 May; 22(10):. PubMed ID: 34069596
[No Abstract] [Full Text] [Related]
14. Distribution of different efflux pump genes in clinical isolates of multidrug-resistant Acinetobacter baumannii and their correlation with antimicrobial resistance.
Lin MF; Lin YY; Tu CC; Lan CY
J Microbiol Immunol Infect; 2017 Apr; 50(2):224-231. PubMed ID: 26055688
[TBL] [Abstract][Full Text] [Related]
15. Risk factors of multidrug resistance in nosocomial bacteremia due to Acinetobacter baumannii: a case-control study.
Shih MJ; Lee NY; Lee HC; Chang CM; Wu CJ; Chen PL; Ko NY; Ko WC
J Microbiol Immunol Infect; 2008 Apr; 41(2):118-23. PubMed ID: 18473098
[TBL] [Abstract][Full Text] [Related]
16. Molecular characterization and antimicrobial susceptibility of Acinetobacter baumannii isolates obtained from two hospital outbreaks in Los Angeles County, California, USA.
Warner WA; Kuang SN; Hernandez R; Chong MC; Ewing PJ; Fleischer J; Meng J; Chu S; Terashita D; English L; Chen W; Xu HH
BMC Infect Dis; 2016 May; 16():194. PubMed ID: 27146090
[TBL] [Abstract][Full Text] [Related]
17. Phenotypic and WGS-derived antimicrobial resistance profiles of clinical and non-clinical Acinetobacter baumannii isolates from Germany and Vietnam.
Wareth G; Linde J; Hammer P; Nguyen NH; Nguyen TNM; Splettstoesser WD; Makarewicz O; Neubauer H; Sprague LD; Pletz MW
Int J Antimicrob Agents; 2020 Oct; 56(4):106127. PubMed ID: 32750418
[TBL] [Abstract][Full Text] [Related]
18. [Molecular characterization of beta-lactamase-associated resistance in Acinetobacter baumannii strains isolated from clinical samples].
Keskin H; Tekeli A; Dolapci İ; Öcal D
Mikrobiyol Bul; 2014 Jul; 48(3):365-76. PubMed ID: 25052103
[TBL] [Abstract][Full Text] [Related]
19. Antibacterial Activity of Gold Nanoparticles Conjugated by Aminoglycosides Against
Rad MR; Kazemian H; Yazdani F; Monfared MRZ; Rahdar H; Javadi A; Kodori M
Recent Pat Antiinfect Drug Discov; 2018; 13(3):256-264. PubMed ID: 30152290
[TBL] [Abstract][Full Text] [Related]
20. An Increasing Threat in an Iranian Referral Children's Hospital: Multidrug-Resistant Acinetobacter baumannii.
Pourakbari B; Mahmoudi S; Habibi R; Ashtiani MTH; Sadeghi RH; Khodabandeh M; Mamishi S
Infect Disord Drug Targets; 2018; 18(2):129-135. PubMed ID: 28088916
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
